4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0000947871-18-000482
Director sold 171,000 shares at an average $13.51 ($2,310,420)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2018-05-30 | Sale | −121,000 | $13.52 | $1,635,920 | 4,970,010 | I |
| ORBIMED ADVISORS LLC Director | 2018-06-01 | Sale | −50,000 | $13.49 | $674,500 | 4,920,010 | I |
| Open-market sales · 171,000 sh · avg $13.51 · $2,310,420 | |||||||
Loading xslF345X03/ss94361_4.xml…